Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“Cross-Collaboration is Key for Cellular Therapies Options Across Cancer Types
The 2025 National ICE_T Symposium gave oncology experts an opportunity to share ideas regarding the administration of cellular therapies. Zahra Mahmoudjafari, spoke with CancerNetwork.”
More posts featuring Cellular Therapies.